BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhuang Y, Han S, Fang Y, Huang H, Wu J. Multidimensional transitional metal-actuated nanoplatforms for cancer chemodynamic modulation. Coordination Chemistry Reviews 2022;455:214360. [DOI: 10.1016/j.ccr.2021.214360] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao Y, Wang K, Zhang J, Duan X, Sun Q, Men K. Multifunctional nanoparticle for cancer therapy. MedComm (2020) 2023;4:e187. [PMID: 36654533 DOI: 10.1002/mco2.187] [Reference Citation Analysis]
2 Lu J, Yang Y, Xu Q, Lin Y, Feng S, Mao Y, Wang D, Wang S, Zhao Q. Recent advances in multi-configurable nanomaterials for improved chemodynamic therapy. Coordination Chemistry Reviews 2023;474:214861. [DOI: 10.1016/j.ccr.2022.214861] [Reference Citation Analysis]
3 Li J, Lu W, Yang Y, Xiang R, Ling Y, Yu C, Zhou Y. Hybrid Nanomaterials for Cancer Immunotherapy. Adv Sci (Weinh) 2023;10:e2204932. [PMID: 36567305 DOI: 10.1002/advs.202204932] [Reference Citation Analysis]
4 Mbugua SN. Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy. Bioinorg Chem Appl 2022;2022:5041399. [PMID: 36568636 DOI: 10.1155/2022/5041399] [Reference Citation Analysis]
5 Pan M, Hu D, Yuan L, Yu Y, Li Y, Qian Z. Newly developed gas-assisted sonodynamic therapy in cancer treatment. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.12.021] [Reference Citation Analysis]
6 Jia T, Li D, Du J, Fang X, Gerasimov V, Ågren H, Chen G. A bimodal type of AgPd Plasmonic Blackbody Nanozyme with boosted catalytic efficacy and synergized photothermal therapy for efficacious tumor treatment in the second biological window. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01627-y] [Reference Citation Analysis]
7 Chen F, Zhang X, Wang Z, Xu C, Hu J, Liu L, Zhou J, Sun B. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy. Biomater Sci 2022. [PMID: 36040793 DOI: 10.1039/d2bm01025a] [Reference Citation Analysis]
8 Ren M, Zhu X, Wang J, Chen L, Cai L, Zhang J, Wang L, Yu Z, Zhou H. Interface-Engineered Mesoporous FeB with Programmed Drug Release for Synergistic Cancer Theranostics. ACS Appl Mater Interfaces 2022. [PMID: 35925798 DOI: 10.1021/acsami.2c09419] [Reference Citation Analysis]
9 He H, Du L, Xue H, Wu J, Shuai X. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy. Acta Biomater 2022:S1742-7061(22)00397-X. [PMID: 35811069 DOI: 10.1016/j.actbio.2022.07.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zhong X, Dai X, Wang Y, Wang H, Qian H, Wang X. Copper-based nanomaterials for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1797. [PMID: 35419993 DOI: 10.1002/wnan.1797] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Su J, Lu S, Wei Z, Li B, Li J, Sun J, Liu K, Zhang H, Wang F. Biocompatible Inorganic Nanoagent for Efficient Synergistic Tumor Treatment with Augmented Antitumor Immunity. Small 2022;:e2200897. [PMID: 35289484 DOI: 10.1002/smll.202200897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]